- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03574207
Estimulação magnética transcraniana direcionada para melhorar as habilidades de memória declarativa dependentes do hipocampo
This is a pilot study of non-invasive transcranial magnetic stimulation (TMS) to improve memory in healthy adults. It will also examine treating memory deficits in older adults with amnestic mild cognitive impairment (aMCI), a condition that frequently precedes Alzheimer's disease (AD). The study will test whether a form of non-invasive brain stimulation repetitive transcranial magnetic stimulation (rTMS) can improve memory abilities in healthy young adults, healthy older adults, and older adults with aMCI by retuning memory-related brain networks. This study is a key first step which will support the long-term goal of treating memory deficits in neurological patients. It is expected that rTMS will improve memory abilities in all participants, and that the improvements in memory will be attributable to changes in the connectivity of memory-related brain networks.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
The investigators propose a pilot study of the potential for non-invasive transcranial magnetic stimulation (TMS) to improve memory in healthy adults (young and old) and to treat memory deficits in older adults with amnestic mild cognitive impairment (aMCI). aMCI is a condition that frequently precedes Alzheimer's disease (AD), and a key symptom of aMCI is clinically significant memory loss (i.e., rapid forgetting) greater than expected for age. The investigators will test whether a form of non-invasive brain stimulation repetitive transcranial magnetic stimulation (rTMS) can improve memory abilities in healthy young adults, healthy older adults, and older adults with aMCI by retuning memory-related brain networks. This study's specific aims are to: 1) Measure changes in declarative memory performance after treatment with targeted rTMS; 2) Measure modulation of functional brain networks after treatment with targeted rTMS. To achieve these aims, the investigators will recruit participants from a standing registry and other sources, test their memory abilities, apply rTMS to a specific brain region, and then test their memory abilities again. As a control, all participants will receive sham rTMS that does not stimulate the brain in one of the two phases of participation. By testing whether real rTMS improves memory abilities more than sham rTMS, the investigators will determine whether rTMS can reliably improve memory in the populations of interest. Also, the investigators will measure changes in brain activity before and after stimulation using magnetic resonance imaging (MRI) and magnetoencephalography (MEG). This study is a key first step which will support the investigators' long-term goal of treating memory deficits in neurological patients. The investigators expect that rTMS will improve memory abilities in all participants, and that the improvements in memory will be attributable to changes in the connectivity of memory-related brain networks. This study has clear clinical and translational relevance because it adapts a novel technique addressing a key symptom of AD to new populations. The investigators expect that the findings will improve the field's understanding of memory loss in healthy aging, aMCI, and AD.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68198
- University of Nebraska Medical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
The investigators anticipate enrolling 48 subjects total:
- 16 healthy young adults (age 19-35)
- 16 healthy older adults (demographically matched to aMCI group for age, sex, and educational attainment)
- 16 older adults diagnosed with amnestic mild cognitive impairment (aMCI)
Inclusion Criteria:
- Adults 19 years of age and older
- Healthy adults without history of psychiatric or neurological disease OR previous diagnosis of amnestic MCI
- Must be able to provide informed consent
- Must have the ability to comply with basic instructions and have the ability to sit comfortably still for TMS, neuroimaging, and other study procedures.
- Right-handed based on self-report (pre-screening) and evaluation with a standard test.
Exclusion Criteria:
- Individuals who have ferrous metal implanted in their body (other than in their teeth) or any other non-removable medical and/or metallic implant
- Individuals who have increased intracranial pressure
- Individuals who have any major medical illness (e.g., cancer, HIV+, hepatitis, heart disease)
- Individuals who have confounding/dual diagnoses (e.g., comorbid mental illness and substance use disorder)
- Individuals with current diagnoses of alcohol or substance abuse/dependence
- Individuals with epilepsy, any history of seizures, or using medication that lowers seizure threshold
- Individuals with any neurological disorder other than aMCI (e.g., stroke, traumatic brain injury)
- Pregnant females --- as determined by urine pregnancy test --- will be excluded from this study due to uncertainty of the effects of MRI and TMS on the fetus
- Not right-handed based on self-report (pre-screening) or evaluation with a standard test
- Not a native English speaker.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Outro: Arm A: Stimulation then Sham
All procedures are identical in both arms with the exception of the order of stimulation administration. In Arm A, transcranial magnetic stimulation (TMS) will be applied in the first week of participation, and sham stimulation will be applied in the second week of participation. |
Transcranial magnetic stimulation non-invasively applies very small amounts of electrical current to brain tissue; sham stimulation uses the same approach but applies little or no actual stimulation to the brain by using less power or greater distance between the head and the stimulator. |
|
Outro: Arm B: Sham then Stimulation
All procedures are identical in both arms with the exception of the order of stimulation administration. In Arm B, sham stimulation will be applied in the first week of participation, and transcranial magnetic stimulation (TMS) will be applied in the second week of participation. |
Transcranial magnetic stimulation non-invasively applies very small amounts of electrical current to brain tissue; sham stimulation uses the same approach but applies little or no actual stimulation to the brain by using less power or greater distance between the head and the stimulator. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in memory performance measured with the number of studied face-word associations recalled
Prazo: Potential changes will be assessed after each one-week rTMS treatment period. Results will be reported at the end of the study (approximately one year).
|
The investigators will measure memory performance before and after treatment to determine whether performance differs as a result of treatment. The main task will be a face-word association task in which participants will study a list of faces paired with single words. After a short delay, one studied face will be presented at a time, and participants will be prompted to recall the word associated with the face. The number of correct face-word associations recalled is the dependent measure. |
Potential changes will be assessed after each one-week rTMS treatment period. Results will be reported at the end of the study (approximately one year).
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in intrinsic functional connectivity between the target brain region stimulated with rTMS and other brain regions.
Prazo: Potential changes will be assessed after each one-week rTMS treatment period. Results will be reported at the end of the study (approximately one year).
|
The investigators will use MRI and MEG to measure brain function before and after treatment to determine whether brain function differs as a result of treatment. |
Potential changes will be assessed after each one-week rTMS treatment period. Results will be reported at the end of the study (approximately one year).
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: David E Warren, PhD, University of Nebraska
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Manifestações Neurológicas
- Doenças do Sistema Nervoso
- Transtornos Mentais, Desordem Mental
- Manifestações Neurocomportamentais
- Distúrbios Neurocognitivos
- Distúrbios Cognitivos
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Disfunção cognitiva
- Distúrbios de memória
- Terapêutica
- Terapia de campo magnético
- Estimulação magnética transcraniana
Outros números de identificação do estudo
- 0096-18-FB
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .